Health
Despite COVID-19 setbacks, WHO aims to eliminate lymphatic filariasis by 2030 – News-Medical.Net
In 2019, 538.1 million people were treated for lymphatic filariasis (LF) in 38 countries that implemented mass drug administration (MDA) of populations at risk…
Reviewed by Emily Henderson, B.Sc.Nov 2 2020
In 2019, 538.1 million people were treated for lymphatic filariasis (LF) in 38 countries that implemented mass drug administration (MDA) of populations at risk of the disease, as recommended by the World Health Organization (WHO).
Seventeen countries achieved the criteria for elimination of LF as a public health problem; Kiribati, Malawi and Yemen were the latest to be acknowledged by WHO.
The Global Programme to Eliminate Lymphatic Filariasis (GPELF)…
-
General19 hours agoVictorian school teacher charged with soliciting child abuse material
-
General10 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Business22 hours agoEconomic roundtable or maturity test?
-
Noosa News14 hours agoPalestine protesters forced into last-minute reroute